Current Problems in Cancer

Papers
(The TQCC of Current Problems in Cancer is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Oncolytic virotherapy: Challenges and solutions51
Nutritional assessment and risk factors associated to malnutrition in patients with esophageal cancer48
Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges37
Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non–small cell lung cancer patients37
The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer33
CAR T-cell therapy for B-cell lymphoma30
Cancer-related malnutrition management: A survey among Italian Oncology Units and Patients’ Associations26
Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer25
Fibrolamellar carcinoma: An entity all its own24
Chordoma: Current status, problems, and future directions22
Monoclonal antibody based radiopharmaceuticals for imaging and therapy18
Exosomal microRNA panels as biomarkers for hematological malignancies18
Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae18
The diagnostic and prognostic roles of serum irisin in bladder cancer17
Depression, anxiety, and their associated factors among Chinese early breast cancer in women under 35 years of age: A cross sectional study16
Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors15
Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from India15
Advances in the management of alveolar soft part sarcoma15
Vaginal intraepithelial neoplasia in patients after total hysterectomy15
Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea15
Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies14
Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients14
Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients With MRI-Radiomics: A Systematic Review and Meta-analysis14
The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study14
Conversion therapy for intrahepatic cholangiocarcinoma and tumor downsizing to increase resection rates: A systematic review13
Risk of lymph node metastasis and prognostic outcome in early gastric cancer patients with mixed histologic type13
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer12
Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: A real-world multicentric cohort analysis from India12
Clinical features and prognostic impact of TCF3–PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China11
Tisotumab vedotin in recurrent or metastatic cervical cancer10
Cancer screenings during the COVID-19 pandemic: An analysis of public interest trends10
Successful management of nongestational ovarian choriocarcinoma complicated with choriocarcinoma syndrome: A case report and a literature review10
Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of “Lung Cancer Management in Indian context”9
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib9
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the management of peritoneal surface malignancies – An evidence-based review9
Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report9
Comparative efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and network meta-analysis9
Disparities in cancer screenings for sexual and gender minorities9
Response to BRAF and MEK1/2 inhibition in a young adult with BRAF V600E mutant epithelioid glioblastoma multiforme: A Case Report and Literature Review9
Prognostic value of visceral pleural invasion in the stage pT1-2N2M0 non-small cell lung cancer: A study based on the SEER registry8
Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study8
Gut microbiota differences in Island Hispanic Puerto Ricans and mainland non-Hispanic whites during chemoradiation for rectal cancer: A pilot study8
The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancer8
Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors8
Neoadjuvant chemotherapy followed by surgery in lung cancer: Indian scenario8
Conventional cardiac risk factors associated with trastuzumab-induced cardiotoxicity in breast cancer: Systematic review and meta-analysis8
Factors associated with mortality from lung cancer in India7
Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization7
A targeted approach to phosphoinositide-3-kinase/Akt/mammalian target of rapamycin-induced hyperglycemia7
Integration of geriatric assessment into clinical oncology practice: A scoping review7
Non-bacterial cystitis secondary to pembrolizumab: A case report and review of the literature7
Immunotherapy for lung cancer: Focusing on chimeric antigen receptor (CAR)-T cell therapy7
Chemotherapy and immune check point inhibitors in the management of cervical cancer7
Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature7
Mucocele-like lesions of the breast - A radiological and clinicopathological analysis7
Using real world data to support regulatory approval of drugs in rare diseases: A review of opportunities, limitations & a case example7
EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management7
Novel approaches for treatment of endometrial carcinoma7
Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC6
Cancer during a pandemic: A psychosocial telehealth intervention for young adults6
Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study6
Cytotoxic chemotherapy in advanced non–small cell lung cancer with poor performance status: A retrospective analysis from routine clinical practice6
Late intracranial metastasis from adenoid-cystic carcinoma of the parotid gland: Imaging, histologic and molecular features6
Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study6
Social determinants of health, workforce diversity, and financial toxicity: A review of disparities in cancer care6
Utility and safety of maintenance chemotherapy in advanced non–small cell lung cancer across various performance status categories: real-world experience6
Kidney cancer: from genes to therapy6
QT interval prolongation related to afatinib treatment in a patient with metastatic non–small-cell lung cancer6
Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis6
Selinexor in patients with advanced and recurrent endometrial cancer5
Changes in the genetic landscape during the malignization of high grade squamous intraepithelial lesion into cervical cancer5
Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy5
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?5
Clinical study of serum IGFBP7 in predicting lymphatic metastasis in patients with lung adenocarcinoma5
Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure5
Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?5
Efficacy of trastuzumab deruxtecan in an advanced gastric cancer patient with brain metastasis5
The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database5
Characteristics of tumor infiltrating lymphocytes in sinonasal mucosal melanoma and prognosis for patients5
Novel prognostic value and potential utility of opioid receptor gene methylation in liquid biopsy for oral cavity cancer5
Impact of active tuberculosis on treatment decisions in cancer5
Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer5
Severe mental illness in cancer is associated with disparities in psycho-oncological support5
Hyperprogressive disease in patients receiving immune checkpoint inhibitors5
Delaying adjuvant chemotherapy in advanced gastric cancer patients: Risk factors and its impact on survival outcome5
Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis5
Seasonal influenza vaccination among cancer patients: A systematic review and meta-analysis of the determinants5
0.021349906921387